Note: Ingredients listed on restricted chemical lists
EC/CAS
200-143-0/52-51-7
Name of the chemical
Bronopol
Concentration
>=0,0025-<
EC/CAS
247-761-7/26530-20-1
Name of the chemical
2-Octyl-2H-isothiazol-3-one
Concentration
>=0,0025-< >=0,0015%
General Information
Version
8.1
Revision date
2024-04-12
Product name
Leather care
1.2.1 Relevant identified uses
Polish, Care product Professional use product
Emergency telephone
+359 2 965 99 55, +359 2 965 99 66, +359 2 9154 233
Icons in SDS
Company Information
company name
ВЮРТ-България ЕООД
e-mail address of the competent person responsible for the Safety Data Sheet
prodsafe@wuerth.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects.
Prevention
P272 Contaminated work clothing should not be allowed out of the workplace. P273 Avoid release to the environment. P280 Wear protective gloves.
Response
P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Hazardous Ingredients
2-Octyl-2H-isothiazol-3-one
Additional information
EUH205 Contains epoxy constituents. May produce an allergic reaction.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
